Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Perspectives on Biomarker and Surrogate Endpoint Evaluation:Discussion Forum Summary (2011) (ISBN 0309163242) Alison Mack, Erin Balogh, and Christine Micheel, Rapporteurs; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010) (ISBN 0309151295) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Evolution of Translational Omics: Lessons Learned and the Path Forward (2012) (ISBN 0309224187) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (2007) (ISBN 030910386X) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• A National Cancer Clinical Trials System for the 21st Century:Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary (2012) (ISBN 0309220645) Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• Improving the Quality of Cancer Clinical Trials:Workshop Summary (2008) (ISBN 0309116686) Margie Patlak and Sharyl Nass, Rapporteurs


• Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (2009) (ISBN 0309131243) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships: Workshop Summary (2008) (ISBN 0309108896) Miriam Davis, Sarah Hanson, Bruce Altevogt, Rapporteurs, Forum on Neuroscience and Nervous System Disorders, Institute of Medicine


• Genome-Based Therapeutics:Targeted Drug Discovery and Development: Workshop Summary (2012) (ISBN 0309260248) Adam C. Berger and Steve Olson, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• Generating Evidence for Genomic Diagnostic Test Development:Workshop Summary (2011) (ISBN 0309211042) Theresa Wizemann and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Institute of Medicine


• Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary (2012) (ISBN 0309253942) Steve Olson and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine


• Policy Issues in the Development of Personalized Medicine in Oncology:Workshop Summary (2010) (ISBN 0309145759) Margie Patlak and Laura Levit, Rapporteurs; Institute of Medicine


• Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary (2011) (ISBN 0309212219) Diana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine


• Scientific Standards for Studies on Modified Risk Tobacco Products (2012) (ISBN 0309223989) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine